Emyria’s data-backed cannabinoid treatments are changing lives
Emyria Limited (ASX: EMD) is an Australian drug development company that focuses on novel treatments for patients with
News
Emyria
Webcast
Emyria Limited Investor Briefing – 17 February
Emyria Limited (ASX: EMD) is a data-backed, drug development company. Emyria’s Treatments target unmet needs and are focused
Webcast
The Insider: Meet the CEOs – 17 February
This week we were joined by the CEOs of exciting ASX listed businesses, who gave valuable insight to